"Rate-Drop Response" Cardiac Pacing for Vasovagal Syncope

Journal of Interventional Cardiac Electrophysiology

Volumn 3, Issue 1, 1999, Pages 27-33

  Benditt, David G ^a   Sutton, Richard ^b   Gammage, Michael ^c   Markowitz, Toby ^d   Gorski, Joanne ^d   Nygaard, Gary ^d   Fetter, Joseph ^d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d MEDTRONIC INC   (United States)

Author keywords

Algorithm; Cardiac pacemaker; Vasovagal syncope

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADOLESCENT; ADULT; AGED; ALGORITHM; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART PACING; HEART RATE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; RECURRENT DISEASE; SYNCOPE; TREATMENT OUTCOME;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CARDIAC PACING, ARTIFICIAL; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; RECURRENCE; SYNCOPE, VASOVAGAL; TREATMENT OUTCOME;

EID: 0033091777     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009815304770     Document Type: Article

References (19)

1. Benditt DG, Lurie KG. Treatment of neurally mediated syncopal syndromes. In: Smith TW, ed. Cardiovascular Therapeutics. Philadelophia: WB Saunders, 1996;368-377.
2. Fitzpatrick AP, Ahmed R, Williams S, et al. A randomized trial of medical therapy in "malignant vasovagal syndrome" or "neurally-mediated bradycardia hypotension syndrome". Eur J Cardiac Pacing Electrophysiol 1991;1:99-102.
3. Brignole M, Menozzi C, Gianfranchi L, et al. A controlled trial of acute and long-term medical therapy in tilt-induced neurally-mediated syncope. Am J Cardiol 1992;70:339-342.
4. Kosinski DJ, Grubb BP. Neurally mediated syncope with an update on indications and usefulness of head-up tilt table testing and pharmacologic therapy. Curr Opinion Cardiol 1994;9:53-64.
5. Morillo C, Leitch JW, Yee R, Klein GJ. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 1993;22:1843-1848.
6. Grubb BP, Wolfe D, Samoil D, Temesy-Armos P, Hahn H, Elliott L. Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope. PACE 1993;16:458-464.
7. Mahanonda N, Bhuripanyo K, Kangkagate C, Wansanit K, Kulchot B, Nademanee K, Chaithiraphan S. Randomized double-blind placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table results. Am Heart J 1995;130(6):1250-1253.
8. Fitzpatrick A, Theodorakis G, Ahmed R, et al. Dual chamber pacing aborts vasovagal syncope induced by head-up 60 degree tilt. PACE 1991;14:13-19.
9. Petersen MEV, Chamberlain-Webber R, Fitzpatrick AP, et al. Permanent pacing for cardio-inhibitory malignant vasovagal syndrome. Br Heart J 1994;71:274-281.
10. Benditt DG, Petersen M, Lurie KG, et al. Cardiac pacing for prevention of recurrent vasovagal syncope. Ann Int Med 1995;122:204-209.
11. Gammage MD, Hess M, Markowitz T. Initial experience with a rate drop algorithm in malignant vasovagal syndrome. Eur J Cardiac Pacing Electrophys 1995;5:45-??.
12. Samoil D, Grubb BP, Brewster P, et al. Comparison of single and dual chamber pacing techniques in prevention of upright tilt induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 1993;1:36-41.
13. Sra J, Jazayeri MR, Avitall B, et al. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med 1993:328″85-1090.
14. Sheldon RS, Gent M, Roberts RS, Connolly SJ, on behalf of the NAVPAC Investigators. North American. Vasovagal Pacemaker Study: Study design and organization. PACE 1997;20:844-848.
15. Sheldon R, Koshman ML, Wilson W, Kieser T, Rose S. Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally-mediated syncope. Am J Cardiol 1998;81:158-162.
16. Benditt DG, Ferguson DW, Grubb BP, Kapoor WN, Kugler J, Lerman BB, Maloney JD, Raviele A, Ross B, Sutton R, Wolk MJ, Wood DL. Tilt-table testing for assessing syncope. An American College of Cardiology expert consensus document. J Am Coll Cardiol 1996;28:263-275.
17. Fish FA, Strasburger JF, Benson DW Jr. Reproducibility of a symptomatic response to upright tilt in young patients with unexplained syncope. Am J Cardiol 1992;70:605-609.
18. Dreifus LS, Fisch C, Griffin JC, et al. Guidelines for implantation of cardiac pacemaker and antiarrhythmic devices. American Heart Association/American College of Cardiology Task Force report. J Am Coll Cardiol 1991;18:1-13.
19. British Pacing and Electrophysiology Group Working Party. Recommendations for pacemaker prescription for symptomatic bradycardia. Br Heart J 1991;66:185-191.